Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd (SHE:301130)
China
· Delayed Price · Currency is CNY 31.96
-0.41 (-1.27%)
Mar 11, 2026, 3:04 PM CST
SHE:301130 Revenue
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd had revenue of 60.63M CNY in the quarter ending September 30, 2025, a decrease of -4.68%. This brings the company's revenue in the last twelve months to 252.77M, up 2.10% year-over-year. In the year 2024, Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd had annual revenue of 256.41M with 13.71% growth.
Revenue (ttm)
252.77M
Revenue Growth
+2.10%
P/S Ratio
9.80
Revenue / Employee
789.90K
Employees
320
Market Cap
2.48B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Anhui Huangshan Capsule | 471.08M |
| Zhejiang Xinguang Pharmaceutical | 257.07M |
| Chengdu huasun technology group Inc. , LTD. | 658.28M |
| Zhejiang Shapuaisi Pharmaceutical | 475.19M |
| Shaanxi Kanghui Pharmaceutical | 513.23M |
| Hainan Huluwa Pharmaceutical Group | 1.06B |
| Enwei Pharmaceutical | 888.64M |
| Guhan Pharmaceutical Group | 351.79M |